Posted On: 09/15/2013 1:32:29 PM
Post# of 72448
Pete, extra kudos to you for honing in on this statement in the slide.
Personally, I would value the rights to use this technology as worth several million. This has reassure me that the acquisition was a fantastic choice and may explain why Leo believes these assets have more intrinsic and extrinsic value then we could possobly fathom.
If polymedix does hold an exclusive license they may also have the rights to sublicense which would bring in revenues. Poly may have been greedy and never wanted to share but a compentent scientist would want others to succeed as well. If my line of thinking here is correct and again I say if. CTIX could sublicense the technology for different drug types so they wouldn't have their technology used to compete against them.
They could set it up so they can allow another company to use it solely to develop say thyroid drugs or diabetes. The sky is the limit.
Personally, I would value the rights to use this technology as worth several million. This has reassure me that the acquisition was a fantastic choice and may explain why Leo believes these assets have more intrinsic and extrinsic value then we could possobly fathom.
If polymedix does hold an exclusive license they may also have the rights to sublicense which would bring in revenues. Poly may have been greedy and never wanted to share but a compentent scientist would want others to succeed as well. If my line of thinking here is correct and again I say if. CTIX could sublicense the technology for different drug types so they wouldn't have their technology used to compete against them.
They could set it up so they can allow another company to use it solely to develop say thyroid drugs or diabetes. The sky is the limit.
(0)
(0)
